CEBP Susan G. Komen for the Cure-AACR Outstanding Investigator Award for Breast Cancer Research Translational Cancer Medicine 2008: Cancer Clinical Trials and Personalized Medicine
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yabroff, K. R.
Right arrow Articles by Ballard-Barbash, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yabroff, K. R.
Right arrow Articles by Ballard-Barbash, R.
Cancer Epidemiology Biomarkers & Prevention Vol. 13, 723-732, May 2004
© 2004 American Association for Cancer Research

What Factors Are Associated with Diagnostic Follow-Up after Abnormal Mammograms? Findings from a U.S. National Survey

K. Robin Yabroff1, Nancy Breen1, Sally W. Vernon2, Helen I. Meissner1, Andrew N. Freedman1 and Rachel Ballard-Barbash1

1 Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, Maryland and 2 University of Texas Houston, School of Public Health, Houston, Texas

Requests for reprints: K. Robin Yabroff, Health Services and Economics Branch/Applied Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Executive Plaza North, Room 4005, 6130 Executive Boulevard, MSC 7344, Bethesda, MD 20892-7344. Phone: (301) 594-1723; Fax: (301) 435-3710. E-mail: yabroffr{at}mail.nih.gov

The purpose of this study was to identify factors associated with diagnostic follow-up after an abnormal mammogram in a national sample of women in the U.S. The sample was selected from the year 2000 National Health Interview Survey and included 1901 women aged 30 and above who reported ever having an abnormal mammogram. The outcome measure was receipt of at least some diagnostic follow-up after an abnormal mammogram. Bivariate and multivariate logistic regression analyses were used to explore the associations between sociodemographic characteristics, general health and health behaviors, cancer risk and risk perceptions, and health care utilization characteristics and follow-up. Approximately 9% of women who reported ever having abnormal mammograms reported not completing any additional diagnostic follow-up. Controlling for all other factors, women with less than a high school education were less likely to report follow-up after an abnormal mammogram than were women who had at least completed college (odds ratio = 0.56; 95% confidence interval: 0.32, 0.98). Younger women and women in poorer health were also less likely to report follow-up. Women who perceived a high versus low level of cancer in their family were more likely to report follow-up (odds ratio = 1.65; 95% confidence interval: 1.04, 2.62), controlling for all other factors. In a national sample of women with abnormal mammograms, a substantial number did not complete any diagnostic follow-up, potentially reducing the effectiveness of mammography screening programs in the U.S. Additional research on subsequent screening behaviors for women with incomplete follow-up and in-depth exploration of the roles of patient-provider interactions and health care system factors related to the index abnormal mammogram is warranted.

Key Words: follow-up studies • mammography • breast neoplasms • mass screening




This article has been cited by other articles:


Home page
Med Care Res RevHome page
C. M. Masi, D. J. Blackman, and M. E. Peek
Interventions to Enhance Breast Cancer Screening, Diagnosis, and Treatment among Racial and Ethnic Minority Women
Med Care Res Rev, October 1, 2007; 64(5_suppl): 195S - 242S.
[Abstract] [PDF]


Home page
Am. J. Public HealthHome page
F. Sassi, H. S. Luft, and E. Guadagnoli
Reducing Racial/Ethnic Disparities in Female Breast Cancer: Screening Rates and Stage at Diagnosis
Am J Public Health, December 1, 2006; 96(12): 2165 - 2172.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
S. S. Gorin, J. E. Heck, B. Cheng, and S. J. Smith
Delays in breast cancer diagnosis and treatment by racial/ethnic group.
Arch Intern Med, November 13, 2006; 166(20): 2244 - 2252.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation
Copyright © 2004 by the American Association for Cancer Research.